UP.AIACT.IN

28 Stakeholders. 4 Editors. 10 Sectors. 1 Uttar Pradesh.

India's first AI Transformation Report and Matrix on the State of Uttar Pradesh, India

The AI Transformation Matrix: Problem Statements

Powered by AIACT.IN, the matrix offers a consolidated version of 77 distinct recommendations in the form of "Sectoral Playbooks" from the UP.AIACT.IN Report 2026.

Access the Report

Clinical Trials, Biotechnology Regulation

Problem Statement

Delays in fast tracking clinical trial clearances and fragmented Institutional Review Board (IRB) approvals across state universities stymie trial initiation.

What is the plausible risk of ignoring the Problem Statement?

Failure to enforce the strict 45 day SLA timeline, causing clinical applications to stagnate inside fragmented university review boards.

Here's what the UP.AIACT.IN Report 2026 Recommends.

Build a dedicated sub portal specifically for life sciences, leveraging the architecture of UP industrial clearance portal, Nivesh Mitra.

Access the Report

What can the UP Government consider as a Policy Mandate based on our specific Recommendation?

The state must establish the Nivesh Mitra Bio Single Window to fast track clinical trial clearances, standardize IRB approvals across state universities, and align state permissions with CDSCO timelines.

What's the AI Intervention Layer in this Recommendation?

Deployment of a unified regulatory sub portal enforcing a strict, automated 45 day Service Level Agreement (SLA) for trial initiation.

Here's how our stakeholders measured impact of our specific Recommendation.

Complete compliance with the 45 day SLA execution timeline for all newly filed clinical trial applications.

What can be some possible Economic Spillover if our Recommendation is implemented?

Lowers administrative friction for international biotechnology firms, positioning the state as a high velocity jurisdiction for life sciences research.

In which Chapter of the UP.AIACT.IN Report 2026 can you find this recommendation?

Chapter 8